A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment.
暂无分享,去创建一个
C. Hamilton | T. Sterling | A. Vernon | D. Conwell | A. Mosher | C. Pachucki | Yong-cheng Wang | N. Bock | M. Samuels